/ world today news/ According to recent reports in the American media, major Western pharmaceutical companies are increasing their investments in China, although they may be affected by the escalation of tensions in Sino-American relations and the reduction of the “dependence” of the United States and Europe on China.
Western pharmaceutical companies such as Pfizer and AstraZeneca have recently said they are committed to helping China deal with the challenges posed by an aging population and have reached relevant cooperation agreements with Chinese companies. Since March this year, executives of many large multinational pharmaceutical companies have begun visits to China. Pfizer, AstraZeneca, Takeda, Merck KGaA and many others have expressed their confidence in the Chinese market and signed a number of cooperation agreements with Chinese companies and provincial governments.
#Large #multinational #pharmaceutical #companies #continue #increase #investment #Chinese #market
